News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Phil Ryan, MD

Articles by Phil Ryan, MD

Recent research investigated the benefits and risks of augmentation compared with switching strategies for TRD in older adults.

Treatment-Resistant Geriatric Depression: Augmenting or Switching an Antidepressant

ByLalangi Marasinghe, MD,Anvesh Jalasutram, MD,Phil Ryan, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

April 17th 2024

Recent research investigated the benefits and risks of augmentation compared with switching strategies for TRD in older adults.

Latest Updated Articles

Treatment-Resistant Geriatric Depression: Augmenting or Switching an Antidepressant
Published: April 17th 2024 | Updated:

Trending on Psychiatric Times

Correctional Psychiatry Enters a New Era: NCCHC Releases 2026 Mental Health Standards

The Deadly Days and What Makes Life Worth Living Better

Presenting Our November Theme: Best Practices

© 2025 MJH Life Sciences^®

All rights reserved.